Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16157079rdf:typepubmed:Citationlld:pubmed
pubmed-article:16157079lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C0005823lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C0012000lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C0039155lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C1521902lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:16157079lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:16157079pubmed:issue5lld:pubmed
pubmed-article:16157079pubmed:dateCreated2005-9-13lld:pubmed
pubmed-article:16157079pubmed:abstractTextThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) Report recommends, as the target for hypertension control, achieving both a systolic and diastolic goal. We suggest, however, that specifying both a systolic and a diastolic component for the blood pressure goal can be confusing to physician and patient. Furthermore, literal interpretation and application of this JNC 7 recommendation could result in overtreatment, undertreatment, or institution of treatment for hypertension when none is needed. Specific scenarios illustrating how inappropriate treatment could result from literal interpretation and application of the JNC 7 recommendations are presented. Our recommended blood pressure goal for hypertensives is: Sitting systolic blood pressure consistently in the 120s or less, if tolerated. This recommendation is evidence based, easy to understand, and achievable. Its rationale is discussed.lld:pubmed
pubmed-article:16157079pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16157079pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16157079pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16157079pubmed:languageenglld:pubmed
pubmed-article:16157079pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16157079pubmed:citationSubsetIMlld:pubmed
pubmed-article:16157079pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16157079pubmed:statusMEDLINElld:pubmed
pubmed-article:16157079pubmed:monthOctlld:pubmed
pubmed-article:16157079pubmed:issn1522-6417lld:pubmed
pubmed-article:16157079pubmed:authorpubmed-author:HebertLee ALAlld:pubmed
pubmed-article:16157079pubmed:authorpubmed-author:ShidhamGanesh...lld:pubmed
pubmed-article:16157079pubmed:authorpubmed-author:HebertChristo...lld:pubmed
pubmed-article:16157079pubmed:issnTypePrintlld:pubmed
pubmed-article:16157079pubmed:volume7lld:pubmed
pubmed-article:16157079pubmed:ownerNLMlld:pubmed
pubmed-article:16157079pubmed:authorsCompleteYlld:pubmed
pubmed-article:16157079pubmed:pagination360-2lld:pubmed
pubmed-article:16157079pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:meshHeadingpubmed-meshheading:16157079...lld:pubmed
pubmed-article:16157079pubmed:year2005lld:pubmed
pubmed-article:16157079pubmed:articleTitleShould the target for blood pressure control specify both a systolic and a diastolic component?lld:pubmed
pubmed-article:16157079pubmed:affiliationCleveland Clinic Foundation, 9500 Euclid Avenue, Mail Drop S70, Cleveland, OH 44195, USA. hebertc@ccf.orglld:pubmed
pubmed-article:16157079pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16157079pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:16157079pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed